Developer docs
API playgroundTry for free, no card

Search company profiles

RemediumOne

Full company profile

uuid003pfie

Namestring
RemediumOne
Legal namestring
RemediumOne Private Limited
Websiteurl
remediumone.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

RemediumOne is a privately-held clinical development organization (CRO) headquartered in Colombo, Sri Lanka, founded in 2009 as a spinoff from the Clinical Trials Unit at the University of Kelaniya. The company delivers end-to-end clinical trial management services—including feasibility, site selection, patient recruitment and retention, monitoring, data management, biostatistics, regulatory support, and pharmacovigilance—across 12+ therapeutic areas (cardiovascular, CNS, endocrine/metabolic, gastroenterology, infectious diseases/vaccines, nephrology, oncology, respiratory, ophthalmology) plus cross-functional capabilities in biosimilars and rare diseases. Its core operational asset is a network of 80+ investigator sites and 300+ investigators across Sri Lanka, supported by 100+ GCP-trained full-time staff, the country's only ACRP-qualified clinical trial monitor, and ISO 9001:2015 and ISO 27001:2022 certifications. RemediumOne also offers adjacent service lines in Medical Affairs, Commercialization (market access, pricing, HEOR), and Consulting, and has launched decentralized clinical trial capabilities (2021) and platform trial participation (CAPTIVATE, 2025).

RemediumOne generates revenue primarily through professional-services contracts—quote-based, customized engagements—with global pharmaceutical sponsors (Takeda, Sanofi, Thermo Fisher, Sun Pharma, J&J, Lilly, Novartis, Gilead, GSK, Boehringer Ingelheim, Glenmark), major CROs (IQVIA, ICON, Parexel, Syneos), and academic institutions (The George Institute, University of Oxford, Imperial College, Duke-NUS, AIIMS, McMaster). Its go-to-market is enterprise field sales via direct partnership relationships, supplemented by thought-leadership channels including the trademarked biennial South Asia Forum and active conference participation. Pricing is not publicly disclosed and contracts are bespoke per engagement. Notable milestones include contributing 70% of global TRIDENT trial data from Sri Lanka (40% reduction in recurrent stroke risk), achieving 98%+ retention rates across trials, and conducting 40+ client/regulatory audits with zero major or critical findings.

Operationally, RemediumOne is positioned as a low-cost, high-quality South Asian alternative to Western CROs, leveraging Sri Lanka's free public healthcare infrastructure, treatment-naive patient populations, predictable regulatory timelines (16-18 weeks from application to FPI), and a non-communicable disease burden mirroring high-income countries. Strategic partnerships include the University of Kelaniya (founding), The George Institute for Global Health, Bill & Melinda Gates Foundation, Unitaid, and membership in the COGNITUM ARO Consortium (2023) and WHO Global Clinical Trial Forum (2025). The company is founder-led with no disclosed external PE/VC capital and remains in private ownership.

Short descriptiontext

RemediumOne is a Sri Lanka-based clinical development organization founded in 2009 that delivers end-to-end clinical trial management, medical affairs, and commercialization services to global pharmaceutical companies, CROs, and academic institutions through an 80+ site investigator network across 12+ therapeutic areas.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersColombo, Sri Lanka
HQ citystring
Colombo
HQ countrystring
Sri Lanka
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial management, clinical research services, site management organization, contract research organization, clinical development solutions
Industry4 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAIALAE
Clinical Development (Phase I–III Trial Design & Execution)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Other Scientific and Technical Consulting Services541690
SIC code2 codes
  • Services-Health Services8000
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Organization (CRO) Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Clinical Trial Management Services
TypeProfessional Services
Description

Full-service clinical trial execution from protocol development through database lock, including site selection, patient recruitment and retention, monitoring, data management, and regulatory support

remediumone.com
2Medical Affairs Services
TypeProfessional Services
Description

Medical science liaison support, scientific publications, medical education, and advisory board facilitation services

remediumone.com
3Commercialization Services
TypeProfessional Services
Description

Market access strategy, pricing and reimbursement, health economics and outcomes research, and product launch planning and execution

remediumone.com
4Consulting Services
TypeProfessional Services
Description

Expert consulting spanning clinical trial design, project management, regulatory affairs, data management, market access, and health economics

remediumone.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1CTU - RemediumOne
Description

Collaborative clinical research centre between Clinical Trials Unit (CTU) at University of Kelaniya and RemediumOne, recognized as the largest collaborative clinical research centre in Sri Lanka

remediumone.com
+3 more records
Core offering1 text field

RemediumOne is a clinical development organization providing end-to-end clinical trial management services in Sri Lanka for global pharmaceutical companies, CROs, and academic institutions. Core offerings span four pillars: Clinical Trials (full-service trial execution from feasibility through database lock, including site management, monitoring, data management, and regulatory support), Medical Affairs (scientific publications and medical education), Commercialisation (market access, pricing/reimbursement, and product launch planning), and Consulting (clinical trial design, regulatory affairs, and market access).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 98%+ retention rate across trials, above industry average
+5 more records
Product overview1 text field

RemediumOne is a clinical development organization offering an integrated suite of clinical research services centered around four core offerings: Clinical Trials (end-to-end trial management), Medical Affairs, Commercialisation, and Consulting. The Clinical Trials service serves as the primary offering, encompassing sub-services including Clinical Trial Monitoring, Phase II-IIIb Services, Clinical Trial Startup, Real World Evidence and Late Phase Trials, Drug Safety and Pharmacovigilance, Medical Writing and Communications, Biostatistics, Clinical Data Management, and Decentralised Solutions. The company operates across multiple therapeutic areas (Cardiovascular, CNS, Endocrine/Metabolic, Gastroenterology, Infectious Diseases/Vaccines, Nephrology, Oncology, Respiratory, Ophthalmology) and offers cross-functional solutions for Biosimilars and Rare Diseases. The portfolio is unified under a quality management system adhering to ISO and ICH-GCP standards, with services customizable to client needs from feasibility through database lock.

Product and service2 records
1Clinical Trials
CategoryClinical Trial Management
Description

End-to-end clinical trial management services spanning site identification to database lock, including protocol development, site selection and management, patient recruitment and retention, data management, statistical analysis, and regulatory support for global pharmaceutical companies, CROs, and academic institutions.

2Medical Affairs
Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership20 partners
1Novaspire Biosciences
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-02-23
Description

Recent MoU signing with Novaspire Biosciences for collaborative clinical development efforts.

remediumone.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

RemediumOne is a founding member of COGNITUM, an ARO (Academic Research Organisation) Consortium bringing together global leaders in scientific and clinical excellence to design and deliver clinical trials while fostering international partnerships.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Long-standing collaboration with The George Institute for Global Health, led by Prof. Anushka Patel (CEO). The partnership has contributed to major global cardiovascular trials including TRIDENT, GMRx2, and COBRA-BPS. Prof. Patel serves on RemediumOne's International Advisory Panel and the organizations co-host the South Asia Forum.

4University of Kelaniya
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Founding partnership with the Clinical Trials Unit at the Faculty of Medicine, University of Kelaniya. This public-private partnership forms the foundation of RemediumOne's operations and has enabled Sri Lanka's contribution to landmark clinical trials. The CTU provides academic oversight and scientific leadership.

remediumone.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

International collaboration with Oxford's renowned clinical trials unit, contributing to the global evidence base for cardiovascular disease treatment and other therapeutic areas.

6Clinical Trials Unit, Imperial College
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaboration with Imperial College London's clinical trials expertise for cardiovascular and other global health research projects.

remediumone.com
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership with Duke University's clinical research institute for exchange of expertise and collaborative research in cardiovascular and other therapeutic areas.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaboration with Duke-NUS in Singapore, co-hosting the South Asia Forum 2021 and contributing to regional clinical research capacity building.

9Stroke Centre, University of Nottingham
Strategic tierMajorTypeStrategic or Co-development Partner
Description

International collaboration focused on stroke research and neurological clinical trials, contributing to global stroke prevention studies.

remediumone.com
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership with McMaster University's public health research institute for collaborative research initiatives.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaboration with AIIMS, India's premier medical research institution, for regional clinical research collaboration.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership with University of Notre Dame for the AEGIS spatial repellent project addressing dengue prevention in Sri Lanka.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Global health foundation partnership for advancing clinical research in areas of unmet need, particularly in infectious diseases and public health.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Unitaid funding for the AEGIS dengue spatial repellent project, providing resources for innovative vector-borne disease prevention research.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership with Takeda for vaccine trials including the DEN-301 dengue vaccine study. Sri Lanka was the second globally to reach enrollment targets of 2,100 subjects for Takeda.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership with Sanofi for immunology and inflammation clinical trials, with positive feedback on team performance and patient-centric approach.

17Sun Pharmaceuticals
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership with Sun Pharmaceuticals' Development Center of Excellence for Specialty Medicine, contributing to historical milestones in clinical development.

remediumone.com
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership with Thermo Fisher Scientific's Early Development division for clinical trial execution in Sri Lanka, with positive feedback on study progress and communication.

19Metrics Research
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

RemediumOne qualified as an Approved Vendor by Metrics Research, enabling engagement in their clinical trial projects.

remediumone.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

University of Kelaniya became a member of the WHO Global Clinical Trial Forum network, expanding RemediumOne's international research network and recognition.

Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

ICON is a top-3 global CRO offering full-service clinical development across all phases and therapeutic areas. Comparable as both a RemediumOne client/partner and a global incumbent competing for the same pharma trial budgets across emerging markets.

TypeBroad incumbent
Description

Syneos Health is a global biopharmaceutical solutions provider combining clinical CRO services with commercialization. Comparable as a RemediumOne partner and a broad incumbent offering integrated clinical and commercialization services that overlap with RemediumOne's medical affairs and commercialization offerings.

TypeBroad incumbent
Description

Parexel is a major global CRO with deep therapeutic expertise across oncology, CNS, and rare disease. Comparable as a RemediumOne partner and a Tier-1 incumbent whose footprint across Asia-Pacific sets the standard for sponsor expectations.

TypeEmerging player
Description

Clario is a clinical trial technology and endpoint solutions company supporting decentralized and hybrid trials. Comparable as an enabling participant in the clinical trial ecosystem, particularly relevant given RemediumOne's investment in decentralized clinical trial capabilities.

TypeDirect peer
Description

Medpace is a mid-sized full-service CRO with strong therapeutic specialization. Comparable as a peer operating in the same clinical development space with a similar focus on full-service trial execution, though Medpace operates globally while RemediumOne is regionally focused.

TypeDirect peer
Description

Worldwide Clinical Trials is a mid-sized global CRO focused on complex therapeutic areas including CNS and cardiometabolic. Comparable as a peer offering full-service clinical development with overlapping therapeutic area focus on cardiovascular and CNS, the two areas where RemediumOne has demonstrated landmark trial contributions.

7Veeda Clinical Research
TypeDirect peer
Description

Veeda Clinical Research is an India-based CRO offering clinical and bioanalytical services across Asia. Comparable as a South Asian regional peer with similar business model of providing cost-effective clinical trial execution for global pharma sponsors.

TypeBroad incumbent
Description

IQVIA is the world's largest CRO with comprehensive Phase I-IV clinical trial services globally. It is comparable as both a potential partner (current client of RemediumOne) and the dominant incumbent whose scale and geographic breadth define the competitive ceiling for regional CROs like RemediumOne.

TypeDirect peer
Description

Lambda Therapeutic Research is an India-based CRO offering bioequivalence and clinical trial services across multiple therapeutic areas. Comparable as a South Asian regional CRO competing for emerging-market trial share with similar therapeutic breadth and Phase II-IV capabilities.

TypeDirect peer
Description

Novotech is an Asia-Pacific-focused CRO specializing in clinical trials across the region, with deep therapeutic expertise. It is the most direct peer to RemediumOne, competing for the same emerging-market trial share with a comparable regional specialization model, though at meaningfully larger scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers18 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RemediumOne

Clinical Research Organization (CRO) Servicesremediumone.com

RemediumOne is a Sri Lanka-based clinical development organization founded in 2009 that delivers end-to-end clinical trial management, medical affairs, and commercialization services to global pharmaceutical companies, CROs, and academic institutions through an 80+ site investigator network across 12+ therapeutic areas.

What RemediumOne does

RemediumOne is a privately-held clinical development organization (CRO) headquartered in Colombo, Sri Lanka, founded in 2009 as a spinoff from the Clinical Trials Unit at the University of Kelaniya. The company delivers end-to-end clinical trial management services—including feasibility, site selection, patient recruitment and retention, monitoring, data management, biostatistics, regulatory support, and pharmacovigilance—across 12+ therapeutic areas (cardiovascular, CNS, endocrine/metabolic, gastroenterology, infectious diseases/vaccines, nephrology, oncology, respiratory, ophthalmology) plus cross-functional capabilities in biosimilars and rare diseases. Its core operational asset is a network of 80+ investigator sites and 300+ investigators across Sri Lanka, supported by 100+ GCP-trained full-time staff, the country's only ACRP-qualified clinical trial monitor, and ISO 9001:2015 and ISO 27001:2022 certifications. RemediumOne also offers adjacent service lines in Medical Affairs, Commercialization (market access, pricing, HEOR), and Consulting, and has launched decentralized clinical trial capabilities (2021) and platform trial participation (CAPTIVATE, 2025).

RemediumOne generates revenue primarily through professional-services contracts—quote-based, customized engagements—with global pharmaceutical sponsors (Takeda, Sanofi, Thermo Fisher, Sun Pharma, J&J, Lilly, Novartis, Gilead, GSK, Boehringer Ingelheim, Glenmark), major CROs (IQVIA, ICON, Parexel, Syneos), and academic institutions (The George Institute, University of Oxford, Imperial College, Duke-NUS, AIIMS, McMaster). Its go-to-market is enterprise field sales via direct partnership relationships, supplemented by thought-leadership channels including the trademarked biennial South Asia Forum and active conference participation. Pricing is not publicly disclosed and contracts are bespoke per engagement. Notable milestones include contributing 70% of global TRIDENT trial data from Sri Lanka (40% reduction in recurrent stroke risk), achieving 98%+ retention rates across trials, and conducting 40+ client/regulatory audits with zero major or critical findings.

Operationally, RemediumOne is positioned as a low-cost, high-quality South Asian alternative to Western CROs, leveraging Sri Lanka's free public healthcare infrastructure, treatment-naive patient populations, predictable regulatory timelines (16-18 weeks from application to FPI), and a non-communicable disease burden mirroring high-income countries. Strategic partnerships include the University of Kelaniya (founding), The George Institute for Global Health, Bill & Melinda Gates Foundation, Unitaid, and membership in the COGNITUM ARO Consortium (2023) and WHO Global Clinical Trial Forum (2025). The company is founder-led with no disclosed external PE/VC capital and remains in private ownership.

RemediumOne firmographics

Firmographics
Name
RemediumOne
Legal name
RemediumOne Private Limited
Website
https://remediumone.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
101–250 employees
Short description
RemediumOne is a Sri Lanka-based clinical development organization founded in 2009 that delivers end-to-end clinical trial management, medical affairs, and commercialization services to global pharmaceutical companies, CROs, and academic institutions through an 80+ site investigator network across 12+ therapeutic areas.
Ownership category
akta.pro rank

RemediumOne industry classification

Industry
Product category
Clinical Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (541690)
SIC
Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAIALAE
Clinical Development (Phase I–III Trial Design & Execution)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Keywords

  • Clinical trial management
  • Clinical research services
  • Site management organization
  • Contract research organization
  • Clinical development solutions

Where RemediumOne is headquartered

Location

Headquarters

HQ city
Colombo
HQ country
Sri Lanka
HQ region
Asia

Offices1 record

Markets served

RemediumOne business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Clinical Trial Management Services: Full-service clinical trial execution from protocol development through database lock, including site selection, patient recruitment and retention, monitoring, data management, and regulatory support
  2. Medical Affairs Services: Medical science liaison support, scientific publications, medical education, and advisory board facilitation services
  3. Commercialization Services: Market access strategy, pricing and reimbursement, health economics and outcomes research, and product launch planning and execution
  4. Consulting Services: Expert consulting spanning clinical trial design, project management, regulatory affairs, data management, market access, and health economics

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

RemediumOne product offering

Product offering

Core offering

RemediumOne is a clinical development organization providing end-to-end clinical trial management services in Sri Lanka for global pharmaceutical companies, CROs, and academic institutions. Core offerings span four pillars: Clinical Trials (full-service trial execution from feasibility through database lock, including site management, monitoring, data management, and regulatory support), Medical Affairs (scientific publications and medical education), Commercialisation (market access, pricing/reimbursement, and product launch planning), and Consulting (clinical trial design, regulatory affairs, and market access).

Product overview

RemediumOne is a clinical development organization offering an integrated suite of clinical research services centered around four core offerings: Clinical Trials (end-to-end trial management), Medical Affairs, Commercialisation, and Consulting. The Clinical Trials service serves as the primary offering, encompassing sub-services including Clinical Trial Monitoring, Phase II-IIIb Services, Clinical Trial Startup, Real World Evidence and Late Phase Trials, Drug Safety and Pharmacovigilance, Medical Writing and Communications, Biostatistics, Clinical Data Management, and Decentralised Solutions. The company operates across multiple therapeutic areas (Cardiovascular, CNS, Endocrine/Metabolic, Gastroenterology, Infectious Diseases/Vaccines, Nephrology, Oncology, Respiratory, Ophthalmology) and offers cross-functional solutions for Biosimilars and Rare Diseases. The portfolio is unified under a quality management system adhering to ISO and ICH-GCP standards, with services customizable to client needs from feasibility through database lock.

Differentiator

Problem solved

Functional benefit

Brands

  • CTU - RemediumOne: Collaborative clinical research centre between Clinical Trials Unit (CTU) at University of Kelaniya and RemediumOne, recognized as the largest collaborative clinical research centre in Sri Lanka
  • COGNITUM ARO Consortium
  • South Asia Forum
  • RemediumOne Global-Monitoring

Products and services

  • Clinical Trials End-to-end clinical trial management services spanning site identification to database lock, including protocol development, site selection and management, patient recruitment and retention, data management, statistical analysis, and regulatory support for global pharmaceutical companies, CROs, and academic institutions.
  • Medical Affairs

Quantifiable outcome

  • 98%+ retention rate across trials, above industry average
  • +5 more outcomes

Companies that use RemediumOne

Customer profile

Named customers18 records

Segments4 records

Ideal customer profiles4 records

RemediumOne technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

RemediumOne partnerships and signals

Strategic signal

Partnerships

20 partnerships are on record, tiered minor, core and major.

  • Novaspire BiosciencesminorStrategic or Co-development Partner · 23 February 2026Recent MoU signing with Novaspire Biosciences for collaborative clinical development efforts.
  • COGNITUM ARO ConsortiumcoreStrategic or Co-development Partner · 1 January 2023RemediumOne is a founding member of COGNITUM, an ARO (Academic Research Organisation) Consortium bringing together global leaders in scientific and clinical excellence to design and deliver clinical trials while fostering international partnerships.
  • The George Institute for Global HealthcoreStrategic or Co-development PartnerLong-standing collaboration with The George Institute for Global Health, led by Prof. Anushka Patel (CEO). The partnership has contributed to major global cardiovascular trials including TRIDENT, GMRx2, and COBRA-BPS. Prof. Patel serves on RemediumOne's International Advisory Panel and the organizations co-host the South Asia Forum.
  • University of KelaniyacoreStrategic or Co-development PartnerFounding partnership with the Clinical Trials Unit at the Faculty of Medicine, University of Kelaniya. This public-private partnership forms the foundation of RemediumOne's operations and has enabled Sri Lanka's contribution to landmark clinical trials. The CTU provides academic oversight and scientific leadership.
  • Clinical Trial Service Unit, University of OxfordcoreStrategic or Co-development PartnerInternational collaboration with Oxford's renowned clinical trials unit, contributing to the global evidence base for cardiovascular disease treatment and other therapeutic areas.
  • Clinical Trials Unit, Imperial CollegemajorStrategic or Co-development PartnerCollaboration with Imperial College London's clinical trials expertise for cardiovascular and other global health research projects.
  • Duke Clinical Research InstitutemajorStrategic or Co-development PartnerPartnership with Duke University's clinical research institute for exchange of expertise and collaborative research in cardiovascular and other therapeutic areas.
  • Duke-NUS Graduate Medical SchoolmajorStrategic or Co-development PartnerCollaboration with Duke-NUS in Singapore, co-hosting the South Asia Forum 2021 and contributing to regional clinical research capacity building.
  • Stroke Centre, University of NottinghammajorStrategic or Co-development PartnerInternational collaboration focused on stroke research and neurological clinical trials, contributing to global stroke prevention studies.
  • Public Health Research Institute, McMaster UniversitymajorStrategic or Co-development PartnerPartnership with McMaster University's public health research institute for collaborative research initiatives.
  • All India Institute of Medical SciencesmajorStrategic or Co-development PartnerCollaboration with AIIMS, India's premier medical research institution, for regional clinical research collaboration.
  • University of Notre DamemajorStrategic or Co-development PartnerPartnership with University of Notre Dame for the AEGIS spatial repellent project addressing dengue prevention in Sri Lanka.
  • Bill & Melinda Gates FoundationcoreStrategic or Co-development PartnerGlobal health foundation partnership for advancing clinical research in areas of unmet need, particularly in infectious diseases and public health.
  • UnitaidcoreStrategic or Co-development PartnerPartnership with Unitaid funding for the AEGIS dengue spatial repellent project, providing resources for innovative vector-borne disease prevention research.
  • Takeda PharmaceuticalsmajorStrategic or Co-development PartnerPartnership with Takeda for vaccine trials including the DEN-301 dengue vaccine study. Sri Lanka was the second globally to reach enrollment targets of 2,100 subjects for Takeda.
  • SanofimajorStrategic or Co-development PartnerPartnership with Sanofi for immunology and inflammation clinical trials, with positive feedback on team performance and patient-centric approach.
  • Sun PharmaceuticalsmajorStrategic or Co-development PartnerPartnership with Sun Pharmaceuticals' Development Center of Excellence for Specialty Medicine, contributing to historical milestones in clinical development.
  • Thermo Fisher ScientificmajorStrategic or Co-development PartnerPartnership with Thermo Fisher Scientific's Early Development division for clinical trial execution in Sri Lanka, with positive feedback on study progress and communication.
  • Metrics ResearchminorChannel Partner/ Reseller/ DistributorRemediumOne qualified as an Approved Vendor by Metrics Research, enabling engagement in their clinical trial projects.
  • WHO Global Clinical Trial ForumcoreStrategic or Co-development PartnerUniversity of Kelaniya became a member of the WHO Global Clinical Trial Forum network, expanding RemediumOne's international research network and recognition.

Scale indicators13 records

Recent moves12 records

Expansion highlights6 records

RemediumOne competitors and assessment

Company assessment

Broad incumbents

  • ICON plc: ICON is a top-3 global CRO offering full-service clinical development across all phases and therapeutic areas. Comparable as both a RemediumOne client/partner and a global incumbent competing for the same pharma trial budgets across emerging markets.
  • Syneos Health: Syneos Health is a global biopharmaceutical solutions provider combining clinical CRO services with commercialization. Comparable as a RemediumOne partner and a broad incumbent offering integrated clinical and commercialization services that overlap with RemediumOne's medical affairs and commercialization offerings.
  • Parexel: Parexel is a major global CRO with deep therapeutic expertise across oncology, CNS, and rare disease. Comparable as a RemediumOne partner and a Tier-1 incumbent whose footprint across Asia-Pacific sets the standard for sponsor expectations.
  • IQVIA: IQVIA is the world's largest CRO with comprehensive Phase I-IV clinical trial services globally. It is comparable as both a potential partner (current client of RemediumOne) and the dominant incumbent whose scale and geographic breadth define the competitive ceiling for regional CROs like RemediumOne.

Emerging players

  • Clario: Clario is a clinical trial technology and endpoint solutions company supporting decentralized and hybrid trials. Comparable as an enabling participant in the clinical trial ecosystem, particularly relevant given RemediumOne's investment in decentralized clinical trial capabilities.

Direct peers

  • Medpace: Medpace is a mid-sized full-service CRO with strong therapeutic specialization. Comparable as a peer operating in the same clinical development space with a similar focus on full-service trial execution, though Medpace operates globally while RemediumOne is regionally focused.
  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO focused on complex therapeutic areas including CNS and cardiometabolic. Comparable as a peer offering full-service clinical development with overlapping therapeutic area focus on cardiovascular and CNS, the two areas where RemediumOne has demonstrated landmark trial contributions.
  • Veeda Clinical Research: Veeda Clinical Research is an India-based CRO offering clinical and bioanalytical services across Asia. Comparable as a South Asian regional peer with similar business model of providing cost-effective clinical trial execution for global pharma sponsors.
  • Lambda Therapeutic Research: Lambda Therapeutic Research is an India-based CRO offering bioequivalence and clinical trial services across multiple therapeutic areas. Comparable as a South Asian regional CRO competing for emerging-market trial share with similar therapeutic breadth and Phase II-IV capabilities.
  • Novotech: Novotech is an Asia-Pacific-focused CRO specializing in clinical trials across the region, with deep therapeutic expertise. It is the most direct peer to RemediumOne, competing for the same emerging-market trial share with a comparable regional specialization model, though at meaningfully larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

RemediumOne social profiles

Digital presence

RemediumOne compliance and trust

Trust signal

Compliance3 records

RemediumOne financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RemediumOne leadership team

Management profile

Number of profiles

Profiles17 records

RemediumOne funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RemediumOne M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RemediumOne

What does RemediumOne do?

RemediumOne is a clinical development organization providing end-to-end clinical trial management services in Sri Lanka for global pharmaceutical companies, CROs, and academic institutions. Core offerings span four pillars: Clinical Trials (full-service trial execution from feasibility through database lock, including site management, monitoring, data management, and regulatory support), Medical Affairs (scientific publications and medical education), Commercialisation (market access, pricing/reimbursement, and product launch planning), and Consulting (clinical trial design, regulatory affairs, and market access).

Is RemediumOne a public or private company?

RemediumOne is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was RemediumOne founded?

RemediumOne was founded in 2009. It employs 101 to 250 people.

Where is RemediumOne based?

RemediumOne is headquartered in Colombo, Sri Lanka, in the Asia region.

How does RemediumOne make money?

Four revenue lines are on record. Clinical Trial Management Services are the primary driver. The others are medical Affairs Services, commercialization Services and consulting Services.

Who are RemediumOne's main competitors?

Broad incumbents on record are ICON plc, Syneos Health, Parexel and IQVIA. Clario is listed as an emerging player. Direct peers are Medpace, Worldwide Clinical Trials, Veeda Clinical Research, Lambda Therapeutic Research and Novotech.

Does RemediumOne have an API?

No public API is recorded for RemediumOne.

What industry is RemediumOne in?

RemediumOne's product category is Clinical Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAIALAE, Clinical Development (Phase I–III Trial Design & Execution). Its NAICS code is 5417 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales